Insights from 2023 ASH Annual Meeting
Avatar

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy & Safety of Dara Monotherapy in Pts With Intermediate- or High-Risk SMM"

By Insights from 2023 ASH Annual Meeting FEATURING Ola Landgren
By Insights from 2023 ASH Annual Meeting FEATURING Ola Landgren
284 views
December 13, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

Penn Medicine Abramson Cancer Center

2025 Breast Cancer Highlights from International Medical Meetings: 5…

Thu, Mar 6, 2025
Total Health

2025 West Oncology Conference

Sat, Feb 8, 2025
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

659 views
15:46

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

436 views
19:08

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

874 views
32:06

Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…

Scripps Health

M. Gertz

528 views
20:00

Smoldering Myeloma: If and When to Treat

Victor Jimenez Zepeda

64 views
15:32

Management of Smoldering Myeloma

XV Eurasian Hematology-Oncology Congress - EHOC 2024

C. Cerchione

63 views
10:37

New

ASH 2024 Insights: Cilta-Cel CAR-T in High-Risk SMM - Results From C…

2024 ASH Annual Meeting Insights Hub

O. Nadeem

29 views
19:35

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Dana-Farber Cancer Institute

Y. Liu

92 views
28:20

Why We Should Not Treat SMM

PleXus Communications

B. Derman

445 views
08:35

Oncologists' Guidance on Treating Smoldering Myeloma: Panel Discussi…

GRACE

A. Goodman, A. Taneja, T. Phillips

133 views
22:15

SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …

5th SOHO Italy Annual Conference

K. Anderson

251 views
04:55

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multi…

Insights from 2023 ASH Annual Meeting

S. Thorsteinsdottir

165 views
04:15

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

714 views
15:56

Smoldering Multiple Myeloma: Cancer or Condition?

Sigrun Thorsteinsdottir

11 views
10:25

SOHO Italy 2023: Is It Time for a Biomarkers-Driven Approach in Smol…

5th SOHO Italy Annual Conference

I. Ghobrial

84 views
32:03

Emerging and Current Treatment of MM: What Should We Know and What S…

Indy Hematology Review

K. Anderson

652 views
13:51

SOHO 2023 DEBATE: Smoldering MM - Time to Watch and Wait

SOHO 2023 Eleventh Annual Meeting

A. Dispenzieri

117 views
52:39

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Yale Cancer Center

A. Chari

525 views
07:20

ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and Dexam…

Insights from 2023 ASH Annual Meeting

O. Nadeem

94 views
10:36

ASH 2023 Insights: "Immuno-PRISM Study of Bispecific Antibodies in H…

Insights from 2023 ASH Annual Meeting

O. Nadeem

99 views
AUTOPLAY